Le Lézard
Classified in: Health
Subjects: PER, SBS

Chris Carles, Christine Holcomb, and Joe DiGregorio Join KJT Group


HONEOYE FALLS, N.Y., Jan. 14, 2019 /PRNewswire/ -- KJT Group is pleased to welcome Chris Carles, Vice President, Consulting Services; Christine Holcomb, Research Director; and Joe DiGregorio, Director, Research Operations.

Chris is a team-oriented healthcare marketing leader, with a consistent record of recommending and executing key customer insight activities to drive results across a broad range of marketing and business development initiatives. In his most recent role at Kaleidoscope Innovation and Product Design, Chris was the Director of Research & Insights, where he demonstrated an ability to leverage primary and secondary market research, connecting disparate pieces of information into a clear picture. Prior to Kaleidoscope Innovation and Product Design, Chris served as Principle at C2 Strategic Consulting, Marketing Research Manager at BD Biosciences, and Senior Manager Market Research at Ethicon Endo-Surgery. Chris received his bachelor's degree in finance from Wright State University.

Christine has over 15 years of experience as a market researcher in the pharmaceutical, biotech, and medical device industries. In her most recent role at MarketVision Research, Inc., Christine was a Research Director, where she successfully designed and executed market research to meet strategic and tactical business objectives. Prior to MarketVision Research, Inc., Christine served as a market research consultant, working at healthcare companies such as Merck. Chris received her bachelor's degree in marketing from LaSalle University.

KJT Group is pleased to welcome Joe back to KJT for a second time, he served as Vice President, Operations from 2009-2012. During this time, Joe laid the foundation for what KJT Group's programming and fielding offering is today. Joe originally came to KJT Group with over 10 years of experience as Director of Survey Programming at Harris Interactive, Inc. After relocating to the Dallas/Fort Worth Area, Joe built on his experience as Senior Director, Global Programming at Instantly, Inc. and Lead Survey Programmer at Critical Mix. Joe received degrees in mathematics from the Rochester Institute of Technology and Nazareth College.

"Chris, Christine and Joe bring decades of experience in the health services research and consulting field to KJT Group. Their skills and expertise are a fantastic complement to our senior leadership team, align perfectly with our organizational values, and will support KJT Group's continued growth," said Lynn Clement, MPH, President, and Global Research at KJT Group. 

About KJT Group: KJT Group (http://www.kjtgroup.com) is an evidence-based consulting firm. Through co-creative partnerships with our life sciences clients, we capture actionable insights that enhance strategic and tactical decision-making. Founded in 2007, KJT Group employs nearly 50 full-time staff across the United States. KJT Group is a member of Intellus Worldwide, the European Pharmaceutical Marketing Research Association (EphMRA), and the British Healthcare Business Intelligence Association (BHBIA).

Media Contact:
Troy Allen, Marketing Manager
KJT Group Inc.
Six East Street
Honeoye Falls, NY, 14472
+1 585-624-8050
[email protected] 

SOURCE KJT Group, Inc.


These press releases may also interest you

at 07:50
The "Peptide Synthesis Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract Manufacturing Organization Size, Key Geographical Regions" report has been added to...

at 07:45
The "Laboratory Filtration Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Laboratory Filtration Equipment Market to Reach $3 Billion by 2030 The global market for Laboratory...

at 07:40
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 07:35
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...

at 07:35
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable Impact of $0.08 Per Share Related to Acquired IPR&D and...

at 07:30
During an awards ceremony to present the 2024 list of Best Workplacestm in Canada, Great Place to Work® announced the 50 Best Workplacestm in Canada with 100-999 employees....



News published on and distributed by: